Tilray, Inc. Contracts & Agreements

133 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Credit Agreement among Aphria Diamond Inc., Aphria Inc., Double Diamond Holdings Ltd., Tilray Brands, Inc., Subsidiary Guarantors, and Canadian Imperial Bank of Commerce
Credit Agreements
Tilray, Inc.
Pharmaceuticals
2025
Non-Interest-Bearing Demand Promissory Note between Aphria Diamond Inc. and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2025
Fourth Amendment and Consent to Credit Agreement among American Beverage Crafts Group, Inc., Bank of America, N.A., and Lenders
Credit Agreements
Tilray, Inc.
Pharmaceuticals
MI
2024
Tilray Brands, Inc. FY 2025 Retention Bonus Agreement with Executive
Retention Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Non-Interest-Bearing Demand Promissory Note between Aphria Diamond Inc. and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2024
Tilray Brands, Inc. FY 2025 Retention Bonus Agreement with Executive
Retention Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Fourth Amended and Restated Wholesale Cannabis Supply Agreement between 1974568 Ontario Limited (Aphria Diamond) and Aphria Inc.
Supply Agreements
Tilray, Inc.
Pharmaceuticals
2024
Waiver to Credit Agreement among Four Twenty Corporation, Guarantors, Lenders, and Bank of America, N.A. (January 5, 2024)
Waiver Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Non-Interest-Bearing Demand Promissory Note between 1974568 Ontario Limited and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2024
Tilray Brands, Inc. 2024 EBITDA Performance Stock Award Grant Notice (Amended and Restated 2018 Equity Incentive Plan)
Bonus & Incentive Agreements
Tilray, Inc.
Pharmaceuticals
2024
Third Amendment and Consent to Credit Agreement among American Beverage Crafts Group, Inc., Guarantors, Lenders, and Bank of America, N.A.
Credit Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Amended and Restated Credit Agreement among Aphria Diamond Inc., Aphria Inc., Tilray Brands, Inc., Subsidiary Guarantors, and Bank of Montreal
Credit Agreements
Tilray, Inc.
Pharmaceuticals
2024
Fourth Amended and Restated Wholesale Cannabis Supply Agreement between 1974568 Ontario Limited (Aphria Diamond) and Aphria Inc.
Supply Agreements
Tilray, Inc.
Pharmaceuticals
2024
Waiver to Credit Agreement among Four Twenty Corporation, Guarantors, Lenders, and Bank of America, N.A. (January 5, 2024)
Waiver Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Non-Interest-Bearing Demand Promissory Note between 1974568 Ontario Limited and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
First Amendment to Securities and Asset Purchase Agreement among Tilray Beverages, LLC, Tilray Brands, Inc., American Beverage Crafts, LLC, and Anheuser-Busch, LLC
Purchase Agreements
Tilray, Inc.
Pharmaceuticals
2023
Second Amendment and Consent to Credit Agreement among Four Twenty Corporation, Bank of America, N.A., and Others
Credit Agreements
Tilray, Inc.
Pharmaceuticals
DE
2023
Securities and Asset Purchase Agreement among Anheuser-Busch, Tilray, and Related Parties (August 7, 2023)
Purchase Agreements
Tilray, Inc.
Pharmaceuticals
WA
2023
Second Supplemental Warrant Indenture among 48North Cannabis Corp., HEXO Corp., Tilray Brands, Inc., and Computershare Trust Company of Canada
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
2023
Third Supplemental Warrant Indenture among Tilray Brands, Inc., HEXO Corp., and Computershare Trust Company of Canada (June 22, 2023)
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
2023
Third Supplemental Warrant Indenture among Tilray Brands, Inc., HEXO Corp., and Computershare Trust Company of Canada (June 22, 2023)
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
2023
Amendment and Consent Agreement between HEXO Corp. and Tilray Brands, Inc. regarding Private Placement and Note Covenants
Modification Agreements
Tilray, Inc.
Pharmaceuticals
2023
Underwriting Agreement for $150,000,000 5.20% Convertible Senior Notes due 2027 by Tilray Brands, Inc. with Jefferies LLC and BofA Securities, Inc.
Underwriting Agreements
Tilray, Inc.
Pharmaceuticals
DC
2023
Non-Interest-Bearing Demand Promissory Note between 1974568 Ontario Limited and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Non-Interest-Bearing Demand Promissory Note between 1974568 Ontario Limited and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Temporary Waiver and Amendment Agreement between HEXO Corp. and Tilray Brands, Inc. (April 2023)
Waiver Agreements
Tilray, Inc.
Pharmaceuticals
2023
Voting Agreement between Double Diamond Holdings Ltd. and Tilray Brands, Inc. (February 21, 2023)
Voting Agreements
Tilray, Inc.
Pharmaceuticals
DE
2023
Assignment and Assumption Agreement between Tilray Brands, Inc. and Double Diamond Holdings Ltd. (September 1, 2022)
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
2023
Non-Interest-Bearing Demand Promissory Note between 1974568 Ontario Limited and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Non-Interest-Bearing Demand Promissory Note between 1974568 Ontario Limited and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Amended and Restated Credit Agreement among 1974568 Ontario Limited, Aphria Inc., Tilray Brands, Inc., and Bank of Montreal, dated November 28, 2022
Credit Agreements
Tilray, Inc.
Pharmaceuticals
2022
Assignment and Assumption Agreement between Tilray Brands, Inc. and Double Diamond Holdings Ltd. (June 30, 2022)
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
2022
Non-Interest-Bearing Demand Promissory Note between 1974568 Ontario Limited and Double Diamond Holdings Ltd.
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022
Executive Employment Agreement between Tilray, Inc. and Mitchell Gendel (Global General Counsel and Corporate Secretary)
Employment Agreements
Tilray, Inc.
Pharmaceuticals
DE
2022
Amending Agreement to Amended and Restated Assignment and Assumption Agreement among Tilray Brands, Inc., HEXO Corp., and HT Investments MA LLC (July 12, 2022)
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
2022
Convertible Promissory Note between Tilray Brands, Inc. and HT Investments MA LLC dated July 12, 2022
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022
HEXO Corp. Amended and Restated Senior Secured Convertible Note due 2026 (HT Investments MA LLC)
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022
Amending Agreement to Transaction Agreement among Tilray Brands, Inc., HEXO Corp., and HT Investments MA LLC (June 14, 2022)
Modification Agreements
Tilray, Inc.
Pharmaceuticals
NY
2022
Amended and Restated Assignment and Assumption Agreement among HT Investments MA LLC, Tilray Brands, Inc., and HEXO Corp.
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
NY
2022
Convertible Promissory Note between Tilray Brands, Inc. and HT Investments MA LLC dated July 2022
Note Agreements
Tilray, Inc.
Pharmaceuticals
DE
2022
Transaction Agreement among Tilray Brands, Inc., HEXO Corp., and HT Investments MA LLC (April 11, 2022)
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
DE
2022
Assignment and Assumption Agreement among HT Investments MA LLC, Tilray Brands, Inc., and HEXO Corp. dated April 11, 2022
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
2022
HEXO Corp. Amended and Restated Senior Secured Convertible Note Due 2026 (HT Investments MA LLC)
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022
Sales Agreement between Tilray Brands, Inc. and Jefferies LLC and Canaccord Genuity LLC (March 3, 2022)
Sales Agreements
Tilray, Inc.
Pharmaceuticals
NY
2022
Second Amendment to Credit Agreement by and among Bank of Montreal, Four Twenty Corporation, and Guarantors (December 7, 2021)
Credit Agreements
Tilray, Inc.
Pharmaceuticals
NY
2022
Employment Agreement between Tilray, Inc. and Irwin D. Simon, Effective July 27, 2021
Employment Agreements
Tilray, Inc.
Pharmaceuticals
NY
2021
Executive Employment Agreement between Tilray, Inc. and Denise Faltischek
Employment Agreements
Tilray, Inc.
Pharmaceuticals
DE
2021
Executive Employment Agreement between Tilray, Inc. and James Meiers (Head of Canada)
Employment Agreements
Tilray, Inc.
Pharmaceuticals
DE
2021
Executive Employment Agreement between Tilray, Inc. and Carl Merton (Chief Financial Officer)
Employment Agreements
Tilray, Inc.
Pharmaceuticals
2021
Assignment and Assumption Agreement among Gotham Green Funds, Superhero Acquisition L.P., and Tilray, Inc. dated August 17, 2021
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
NY
2021
Assignment and Assumption Agreement among Parallax Master Fund, L.P., Superhero Acquisition L.P., and Tilray, Inc. dated August 17, 2021
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
NY
2021
Assignment and Assumption Agreement among Pura Vida Master Fund, Pura Vida Pro Special Opportunity Master Fund, Superhero Acquisition L.P., and Tilray, Inc. dated August 17, 2021
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
NY
2021
Amendment to Arrangement Agreement between Aphria Inc. and Tilray, Inc. (February 19, 2021)
Modification Agreements
Tilray, Inc.
Pharmaceuticals
2021
First Amendment to Product & Trademark Licensing Agreement between Docklight Brands, Inc. and High Park Holdings, Ltd.
License Agreements
Tilray, Inc.
Pharmaceuticals
2021
Arrangement Agreement Between Tilray, Inc. and Aphria Inc. Dated December 15, 2020
Plan of Reorganization Agreements
Tilray, Inc.
Pharmaceuticals
DE
2020
One-Time Incentive Payment Agreements between Tilray, Inc. and Michael Kruteck & Jon Levin
Bonus & Incentive Agreements
Tilray, Inc.
Pharmaceuticals
2020
Amendment to Employment Agreement between Tilray, Inc. and Jon Levin
Employment Agreements
Tilray, Inc.
Pharmaceuticals
2020
First Amendment to Loan Facility Letter Agreement among Bridging Finance Inc., High Park Holdings Ltd., and Guarantors (June 5, 2020)
Modification Agreements
Tilray, Inc.
Pharmaceuticals
2020
Tilray, Inc. Employment Agreement with Kathryn P. Dickson (President, Manitoba Harvest)
Employment Agreements
Tilray, Inc.
Pharmaceuticals
WA
2020
Amended and Restated Profit Participation Agreement between ABG Intermediate Holdings 2, LLC and Tilray, Inc.
Profit Sharing Plans
Tilray, Inc.
Pharmaceuticals
NY
2020
First Amendment to Payment Agreement between Tilray, Inc. and ABG Intermediate Holdings 2, LLC
Modification Agreements
Tilray, Inc.
Pharmaceuticals
2020
Tilray Canada, Ltd. Employment Agreement with Andrew Pucher (Chief Corporate Development Officer)
Employment Agreements
Tilray, Inc.
Pharmaceuticals
2020
Tilray, Inc. Employment Agreement with Jon Levin (Chief Operating Officer)
Employment Agreements
Tilray, Inc.
Pharmaceuticals
WA
2020
Tilray, Inc. Employment Agreement with Michael Kruteck (Chief Financial Officer)
Employment Agreements
Tilray, Inc.
Pharmaceuticals
WA
2020
Guarantee Agreement among Tilray, Inc. and Affiliates and Bridging Finance Inc. dated February 28, 2020
Guaranty Agreements
Tilray, Inc.
Pharmaceuticals
2020
US Pledge and Security Agreement among Tilray, Inc., Manitoba Harvest USA, LLC, and Bridging Finance Inc. (February 28, 2020)
Pledge Agreements
Tilray, Inc.
Pharmaceuticals
NY
2020
Lock-up Agreement between Tilray, Inc. and Privateer Holdings Stockholders (2019 Merger)
Tilray, Inc.
Pharmaceuticals
2019
Tilray, Inc. $400,000,000 Sales Agreement with Cowen and Company, LLC (September 10, 2019)
Sales Agreements
Tilray, Inc.
Pharmaceuticals
NY
2019
Payment Agreement between Tilray, Inc. and ABG Intermediate Holdings 2, LLC (January 14, 2019)
Purchase Agreements
Tilray, Inc.
Pharmaceuticals
NY
2019
Arrangement Agreement among 1197879 B.C. Ltd., FHF Holdings Ltd., Tilray, Inc., Shareholder Representative, and Shareholders (February 19, 2019)
Merger Agreements
Tilray, Inc.
Pharmaceuticals
2019
Arrangement Agreement among Tilray, Inc., High Park Gardens Inc., and Natura Naturals Holdings Inc. (January 21, 2019)
Plan of Reorganization Agreements
Tilray, Inc.
Pharmaceuticals
2019
U.S. Underwriting Agreement between Tilray, Inc. and Cowen and Company, LLC (2018)
Underwriting Agreements
Tilray, Inc.
Pharmaceuticals
NY
2018
Tilray, Inc. Amended and Restated 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Tilray, Inc.
Pharmaceuticals
DE
2018
Tilray, Inc. Employment Agreement with Brendan Kennedy (CEO and President)
Employment Agreements
Tilray, Inc.
Pharmaceuticals
WA
2018
Employment Agreement between Tilray, Inc. and Mark Castaneda
Employment Agreements
Tilray, Inc.
Pharmaceuticals
WA
2018
Employment Agreement between Tilray, Inc. and Edward Wood Pastorius, Jr.
Employment Agreements
Tilray, Inc.
Pharmaceuticals
WA
2018
Credit Facility Agreement between Privateer Holdings, Inc. and Lafitte Ventures, Ltd.
Credit Agreements
Tilray, Inc.
Pharmaceuticals
WA
2018
Clarification of Credit Facility Agreement between Privateer Holdings, Inc. and Tilray Canada, Ltd.
Credit Agreements
Tilray, Inc.
Pharmaceuticals
2018
Construction Facility Agreement between Privateer Holdings, Inc. and Bouchard Ventures, Ltd.
Facility Agreements
Tilray, Inc.
Pharmaceuticals
WA
2018
Trademark License Agreement between Docklight LLC and Licensee
Trademark Agreements
Tilray, Inc.
Pharmaceuticals
WA
2018
Description of Tilray Brands, Inc. Capital Stock Registered Under Section 12(b) of the Exchange Act
Equity Distribution Agreements
Tilray, Inc.
Pharmaceuticals
2024
Equity Distribution Agreement between Tilray Brands, Inc. and TD Securities (USA) LLC and Jefferies LLC, dated May 17, 2024
Equity Distribution Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Tilray Brands, Inc. 2023 EBITDA Performance Restricted Stock Unit Grant Notice (Amended and Restated 2018 Equity Incentive Plan)
Equity Distribution Agreements
Tilray, Inc.
Pharmaceuticals
2023
Description of Tilray Brands, Inc. Class 2 Common Stock and Preferred Stock Rights
Stock Agreements
Tilray, Inc.
Pharmaceuticals
2023
Supplemental Warrant Indenture among HEXO Corp., Tilray Brands, Inc., and TSX Trust Company (June 22, 2023)
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Supplemental Warrant Indenture among HEXO Corp., Tilray Brands, Inc., and TSX Trust Company (June 22, 2023)
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Supplemental Warrant Indenture among HEXO Corp., Tilray Brands, Inc., and TSX Trust Company (June 22, 2023)
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Supplemental Warrant Indenture among HEXO Corp., Tilray Brands, Inc., and TSX Trust Company (June 22, 2023)
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Amendment to Arrangement Agreement between Tilray Brands, Inc. and HEXO Corp. (June 1, 2023)
Merger Agreements
Tilray, Inc.
Pharmaceuticals
2023
Indenture Agreement between Tilray Brands, Inc. and Computershare Trust Company, N.A. dated May 31, 2023
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
DE
2023
First Supplemental Indenture to 5.20% Convertible Senior Notes due 2027 between Tilray Brands, Inc. and Computershare Trust Company, N.A.
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
DE
2023
Share Lending Agreement between Tilray Brands, Inc. and Jefferies Capital Services, LLC dated May 25, 2023
Loan Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Arrangement Agreement between Tilray Brands, Inc. and HEXO Corp. dated April 10, 2023
Merger Agreements
Tilray, Inc.
Pharmaceuticals
DE
2023
Tilray Brands, Inc. Restricted Stock Unit Grant Notice (2022 HEXO EBITDA Award) under Amended and Restated 2018 Equity Incentive Plan
Equity Distribution Agreements
Tilray, Inc.
Pharmaceuticals
2022
Description of Tilray Brands, Inc. Class 2 Common Stock and Preferred Stock Rights
Equity Distribution Agreements
Tilray, Inc.
Pharmaceuticals
2022
Indenture Agreement between HEXO Corp. and GLAS Trust Company LLC dated May 27, 2021
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NY
2022
Agreement of Resignation, Appointment and Acceptance among Tilray Brands, Inc., Computershare Trust Company, N.A., and GLAS Trust Company LLC
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
CO
2022
Agreement of Resignation, Appointment and Acceptance among Tilray Brands, Inc., GLAS Trust Company LLC, and Computershare Trust Company, N.A.
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
2022
Agreement of Resignation, Appointment and Acceptance among Tilray Brands, Inc., Computershare Trust Company, N.A., and GLAS Trust Company LLC (January 27, 2022)
Trust Agreements
Tilray, Inc.
Pharmaceuticals
CO
2022
Aphria Inc. and GLAS Trust Company LLC Indenture for 5.25% Convertible Senior Notes Due 2024
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NY
2021
First Indenture Supplement among Aphria Inc., Tilray, Inc., and GLAS Trust Company LLC dated April 30, 2021
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NY
2021
Separation Agreement and Complete Release between Michael Kruteck and Tilray Inc.
Separation Agreements
Tilray, Inc.
Pharmaceuticals
2021
Separation Agreement and Complete Release between Jon Levin and Tilray Inc.
Separation Agreements
Tilray, Inc.
Pharmaceuticals
2021
Description of Tilray, Inc. Class 2 Common Stock and Preferred Stock Rights
Equity Distribution Agreements
Tilray, Inc.
Pharmaceuticals
2021
Product and Trademark License Agreement between Docklight, LLC and Licensee
License Agreements
Tilray, Inc.
Pharmaceuticals
WA
2021
Separation and Release Agreement between Tilray Inc. and Andrew Pucher dated February 8, 2021
Separation Agreements
Tilray, Inc.
Pharmaceuticals
2021
Voting Support Agreement between Tilray, Inc. and Certain Aphria Shareholders
Voting Agreements
Tilray, Inc.
Pharmaceuticals
2020
Voting Support Agreement between Aphria Inc. and Certain Tilray Shareholders (December 15, 2020)
Voting Agreements
Tilray, Inc.
Pharmaceuticals
2020
Separation Agreement and Complete Release between Edward Pastorius Jr and Tilray Inc.
Separation Agreements
Tilray, Inc.
Pharmaceuticals
2020
Tilray, Inc. Indemnity Agreement with Director, Officer, Employee, or Agent
Indemnification Agreements
Tilray, Inc.
Pharmaceuticals
DE
2020
Tilray, Inc. Prepaid Warrant to Purchase Class 2 Common Stock (March 2020)
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
NY
2020
Tilray, Inc. Warrant to Purchase Class 2 Common Stock (March 2020)
Warrant Agreements
Tilray, Inc.
Pharmaceuticals
NY
2020
Tilray, Inc. Underwriting Agreement with Canaccord Genuity LLC for Common Stock and Warrants Offering
Underwriting Agreements
Tilray, Inc.
Pharmaceuticals
NY
2020
Description of Tilray, Inc. Class 2 Common Stock Registered Under Section 12(b) of the Exchange Act
Equity Distribution Agreements
Tilray, Inc.
Pharmaceuticals
2020
Profit Participation Agreement between ABG Intermediate Holdings 2, LLC and Tilray, Inc. (January 14, 2019)
Participation Agreements
Tilray, Inc.
Pharmaceuticals
NY
2020
Loan Facility Agreement between High Park Holdings Ltd. and Bridging Finance Inc. (February 28, 2020)
Loan Agreements
Tilray, Inc.
Pharmaceuticals
2020
Canadian Security Agreement between High Park Holdings Ltd., Guarantors, and Bridging Finance Inc. dated February 28, 2020
Security Agreements
Tilray, Inc.
Pharmaceuticals
2020
Support Agreement among Tilray, Inc., Privateer Holdings, Inc., and Stockholder Regarding Merger Approval
Voting Agreements
Tilray, Inc.
Pharmaceuticals
DE
2019
Lock-up Agreement (Termination) between Tilray, Inc. and Shareholder (September 9, 2019)
Tilray, Inc.
Pharmaceuticals
2019
Agreement and Plan of Merger and Reorganization among Tilray, Inc., Down River Merger Sub, LLC, and Privateer Holdings, Inc.
Merger Agreements
Tilray, Inc.
Pharmaceuticals
DE
2019
Profit Participation Agreement between ABG Intermediate Holdings 2, LLC and Tilray, Inc.
Participation Agreements
Tilray, Inc.
Pharmaceuticals
NY
2019
Amending Agreement to Arrangement Agreement among 1197879 B.C. Ltd., Tilray, Inc., FHF Holdings Ltd., and Compass Group Diversified Holdings, LLC (February 27, 2019)
Modification Agreements
Tilray, Inc.
Pharmaceuticals
2019
Indenture for 5.00% Convertible Senior Notes due 2023 between Tilray, Inc. and GLAS Trust Company LLC
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NH
2018
Canadian Underwriting Agreement for Tilray, Inc. Class 2 Common Stock with BMO Nesbitt Burns Inc. and Eight Capital
Underwriting Agreements
Tilray, Inc.
Pharmaceuticals
2018
Tilray, Inc. Stock Option Agreement under Amended and Restated 2018 Equity Incentive Plan
Stock Agreements
Tilray, Inc.
Pharmaceuticals
2018
Tilray, Inc. Restricted Stock Unit Award Agreement under Amended and Restated 2018 Equity Incentive Plan
Equity Distribution Agreements
Tilray, Inc.
Pharmaceuticals
2018
Indemnity Agreement between Tilray, Inc. and Indemnitee
Indemnification Agreements
Tilray, Inc.
Pharmaceuticals
DE
2018
Board Services Agreement between Tilray, Inc. and Michael Auerbach
Services Agreements
Tilray, Inc.
Pharmaceuticals
DE
2018
Board Services Agreement between Tilray, Inc. and Rebekah Samuel (aka Rebekah Dopp)
Services Agreements
Tilray, Inc.
Pharmaceuticals
DE
2018
Board Services Agreement between Tilray, Inc. and Maryscott Greenwood
Services Agreements
Tilray, Inc.
Pharmaceuticals
DE
2018
Board Services Agreement between Tilray, Inc. and Christine St. Clare
Services Agreements
Tilray, Inc.
Pharmaceuticals
DE
2018
Tilray, Inc. Investor Rights Agreement with Series A Preferred Stock Investors and Key Holders (February 5, 2018)
Investor Rights Agreements
Tilray, Inc.
Pharmaceuticals
WA
2018
Corporate Services Agreement between Privateer Holdings, Inc. and Client Company
Services Agreements
Tilray, Inc.
Pharmaceuticals
WA
2018